Lithium specificity in bipolar illness: a classic agent for the classic disorder
- 1 June 2009
- journal article
- review article
- Published by Wiley in Bipolar Disorders
- Vol. 11 (s2), 34-44
- https://doi.org/10.1111/j.1399-5618.2009.00709.x
Abstract
For over half a century, lithium has been the gold standard amongst the pharmacological armamentarium used to treat bipolar disorder. Its ascendancy in this regard has been attributed partly to its primacy of discovery and clinical implementation; however, it is important to consider how it has achieved success and retained its prominence and whether this is because of its unique profile and specificity of actions. In this paper, we briefly discuss the clinical evidence in support of lithium specificity and argue for its continuing use in those patients most likely to benefit, namely, patients with 'classic' bipolar disorder. Further, we suggest that accurate characterization of 'lithium responders' through focused research is likely to yield novel treatments and assist in better understanding of the pathophysiology of the illness. In addition, the unique antisuicidal actions of lithium warrant further examination, as do its impressive properties as a prophylactic agent. This is particularly so given the high morbidity associated with bipolar disorder and its potential for suicide. Hence, in this paper, after describing the changing diagnostic backdrop against which much of the research to date has been conducted, we discuss the clinical therapeutic profile of lithium in both the acute and long-term management of bipolar disorder and its phenotypic specificity of action. We demonstrate that lithium possesses significant clinical and therapeutic efficacy that is very individual and thus remains the treatment of choice for bipolar disorder when used specifically in select patients.Keywords
This publication has 104 references indexed in Scilit:
- The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisBipolar Disorders, 2009
- Clinical practice recommendations for depressionActa Psychiatrica Scandinavica, 2009
- Upping the ante on antidepressantsBipolar Disorders, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyThe New England Journal of Medicine, 2008
- Schizoaffective disorder: diagnostic issues and future recommendationsBipolar Disorders, 2008
- Effectiveness of Adjunctive Antidepressant Treatment for Bipolar DepressionThe New England Journal of Medicine, 2007
- Deconstructing Bipolar Disorder: A Critical Review of its Diagnostic Validity and a Proposal for DSM-V and ICD-11Schizophrenia Bulletin, 2007
- Maintenance therapies for classic and other forms of bipolar disorderJournal of Affective Disorders, 2000
- The effect of long‐term lithium treatment on the mortality of patients with manic‐depressive and schizoaffective illness*Acta Psychiatrica Scandinavica, 1992
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentThe New England Journal of Medicine, 1988